Skip to main content
UniHealth

Doctor search

Quan Dong Nguyen, MD

Ophthalmology · Stanford

NPI 1487608766

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
22
4 carriers
Offices
3

Offices

3 locations · Stanford Health Care · County of Santa Clara

Looking this up.

Hospitals listed: Santa Clara Valley Medical Center · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

22 plans · 4 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nguyen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

22 of 22 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
Central Health Classic Care Plan III (HMO)Central Health Medicare PlanListedAug 15, 2026
Central Health Dual Access Plan (HMO D-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Embrace Care Plan (HMO C-SNP)Central Health Medicare PlanListed, may be out of dateSep 15, 2025
Central Health Embrace Choice Plan (HMO C-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Valor Care Plan (HMO)Central Health Medicare PlanListedAug 15, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence G144498 · Current

Licensed to practise in California · since 2016 · expires 2028-07-31 · University of Pennsylvania School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

3 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend it
    Overall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Santa Clara Valley Medical Center
SSI - Colon SurgeryInfections2.572WorseOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.563BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.256BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.369BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.25 (0.3 to 2.2) · 1,535 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.07 (0.76 to 1.38)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths214.59 (167.38 to 261.8) · 108 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.8 · 41 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6 · 141 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.2 · 124 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.3 · 501 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.9 · 653 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 348 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 4,502 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.24 (0.04 to 0.43) · 9,014 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.34 (0.15 to 0.52) · 9,216 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.54 (2.51 to 6.58) · 1,421 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.54 (0 to 3.2) · 288 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.66 to 3.56) · 1,446 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths11.61 (4.09 to 19.14) · 294 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.29 (3.39 to 11.2) · 299 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.9 (0.45 to 3.36) · 333 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.23 (0 to 0.78) · 7,538 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths5.4 · 94 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.735No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections2.573No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.6 · 185 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.1 · 951 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits56.3 · 128 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits6.4 · 644 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits1.3 · 699 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.3 · 921 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (3.9 to 8.1) · 226 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.6 (9.4 to 16.5) · 226 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.4 · 94 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits11.4 · 54 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.3 · 242 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.2 (9.9 to 17.4) · 702 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.7 to 1.4) · 195 casesNo differentJan 2024 – Dec 2024

What patients said (4,032 patients answered, 29% of those asked)

Patient survey stars by topic at Santa Clara Valley Medical Center
Cleanliness3
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information2
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Santa Clara Valley Medical Center
Room was "always" clean70%
Nurses "always" communicated well73%
Doctors "always" communicated well76%
Staff "always" explained57%
Yes, staff "did" give patients this information82%
Yes, staff "did" give patients information about help after discharge82%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully74%
Doctors "always" treated them with courtesy and respect82%
Patients who gave a rating of "9" or "10" (high)67%
Staff "always" explained new medications71%
Nurses "always" explained things so they could understand71%
Nurses "always" listened carefully69%
Nurses "always" treated them with courtesy and respect80%
"Always" quiet at night43%
"YES", patients would definitely recommend the hospital70%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms83%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$37,431

Medicare paid this office $37,431 for 147 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)127$22,625$117
Imaging of retina104$2,767$21
Exam of retinal blood vessels using a special camera after injection of a dye54$2,256$36
Extended exam of the back part of the eye with retinal drawing56$1,209$19
Measurement of retinal and optic nerve function24$689$29
See all 8 services
Every Original Medicare service billed
Long return visit (40+ min)127$22,625$117
Imaging of retina104$2,767$21
Exam of retinal blood vessels using a special camera after injection of a dye54$2,256$36
Extended exam of the back part of the eye with retinal drawing56$1,209$19
Measurement of retinal and optic nerve function24$689$29
Measurement of retinal and optic nerve function targeting multiple separate locations24$645$27
Exam of visual field with extended testing18$449$24
Photography of content of eyes35$99$3

Procedures Medicare counted

Procedure volume Medicare published
Cataract surgery1-10None

Who their Medicare patients are

147 Original Medicare patients in 2024. Average age 72 · Under 65 12% · 85 and older 8% · Women 65% · Also on Medicaid 29% · Health risk score 1.25. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 65% · Diabetes 35% · Chronic kidney disease 20% · Depression 18% · Coronary heart disease 16% · Atrial fibrillation 15% · Heart failure 13% · Cancer 13% · COPD 10% · Stroke 9%.

The office billed $173,514, Medicare allowed $51,304 and paid $37,431; for 625 services of 28 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024147625721.25$173,514$37,431
2023129791721.20$227,454$51,320
20221411,006711.25$188,975$50,725
20211431,286711.46$212,098$61,784
2020123980721.63$173,071$48,059
2019104901721.61$147,808$41,430
201875581731.52$106,598$27,737
201747329731.68$50,730$14,276
201661532721.06$152,013$37,048
201586807701.19$208,357$52,352
201461644690.93$206,180$54,437
201364454730.91$134,869$38,480

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 10 services

Original Medicare services billed in 2023
Long return visit (40+ min)111$25,991$121
Imaging of retina108$4,250$23
Exam of retinal blood vessels using a special camera after injection of a dye49$2,454$37
New patient visit (60+ min)11$1,837$167
Extended exam of the back part of the eye with retinal drawing70$1,667$19
Measurement of retinal and optic nerve function22$837$35
Measurement of retinal and optic nerve function targeting multiple separate locations18$635$32
Extended exam of the back part of the eye with optic nerve drawing33$490$13
Exam of visual field with extended testing11$335$26
Photography of content of eyes33$140$3

2022: 9 services

Original Medicare services billed in 2022
Long return visit (40+ min)117$25,494$116
Imaging of retina121$5,446$22
Exam of retinal blood vessels using a special camera after injection of a dye54$2,773$37
Extended exam of the back part of the eye with optic nerve drawing105$2,455$13
Return visit (30+ min)22$1,983$83
Exam of visual field with extended testing22$590$22
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or16$500$29
Extended exam of the back part of the eye with retinal drawing21$430$20
Photography of content of eyes41$186$3

2021: 11 services

Original Medicare services billed in 2021
Long return visit (40+ min)116$29,448$116
Imaging of retina126$7,750$24
Exam of retinal blood vessels using a special camera after injection of a dye64$3,671$39
Extended exam of the back part of the eye with optic nerve drawing100$2,861$13
Injection of drug into eye11$2,629$91
New patient visit (60+ min)14$2,407$172
Return visit (30+ min)13$1,630$91
Exam of visual field with extended testing22$809$23
Extended exam of the back part of the eye with retinal drawing35$700$20
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or13$450$30
Photography of content of eyes48$306$3

2020: 9 services

Original Medicare services billed in 2020
Long return visit (40+ min)97$22,250$97
Imaging of retina105$5,649$23
Extended exam of the back part of the eye with retinal drawing93$3,246$20
New patient visit (60+ min)21$3,148$150
Exam of retinal blood vessels using a special camera after injection of a dye34$2,198$42
Photography of the retina13$1,002$20
Extended exam of the back part of the eye with optic nerve drawing34$548$14
Exam of visual field with extended testing13$429$27
Photography of content of eyes47$266$3

2019: 8 services

Original Medicare services billed in 2019
Long return visit (40+ min)81$18,741$95
Imaging of retina87$4,794$23
New patient visit (60+ min)19$2,894$152
Examination of eye by ophthalmoscope with retinal drawing53$2,588$17
Exam of retinal blood vessels using a special camera after injection of a dye40$2,462$40
Examination of eye by ophthalmoscope with retinal drawing37$1,534$20
Photography of the retina11$269$21
Photography of content of eyes41$266$3

2018: 8 services

Original Medicare services billed in 2018
Long return visit (40+ min)59$10,511$91
New patient visit (60+ min)21$3,007$143
Imaging of retina62$2,804$22
Exam of retinal blood vessels using a special camera after injection of a dye46$2,236$37
Return visit (30+ min)22$2,190$63
Examination of eye by ophthalmoscope with retinal drawing27$1,140$15
Examination of eye by ophthalmoscope with retinal drawing25$832$18
Photography of content of eyes32$158$3

2017: 8 services

Original Medicare services billed in 2017
Long return visit (40+ min)34$4,583$100
New patient visit (60+ min)17$2,517$148
Exam of retinal blood vessels using a special camera after injection of a dye39$1,800$40
Return visit (30+ min)16$1,552$71
Imaging of retina42$1,375$23
Examination of eye by ophthalmoscope with retinal drawing31$1,156$19
Examination of eye by ophthalmoscope with retinal drawing15$748$18
Photography of content of eyes14$64$3

2016: 8 services

Original Medicare services billed in 2016
Exam of retinal blood vessels using a special camera after injection of a dye43$7,839$110
Return visit (30+ min)44$4,320$66
Photography of the retina53$3,802$42
Examination of eye by ophthalmoscope with retinal drawing48$2,437$18
Long return visit (40+ min)12$1,678$88
New patient visit (60+ min)12$1,615$135
Imaging of retina14$437$26
Examination of eye by ophthalmoscope with retinal drawing11$436$20

2015: 10 services

Original Medicare services billed in 2015
Exam of retinal blood vessels using a special camera after injection of a dye59$14,937$132
Photography of the retina74$7,177$50
Return visit (30+ min)49$6,311$74
Long return visit (40+ min)31$4,294$93
Examination of eye by ophthalmoscope with retinal drawing67$3,827$19
Established patient complete exam of visual system31$2,741$72
Imaging of retina17$879$30
Exam of visual field with extended testing11$698$44
Examination of eye by ophthalmoscope with retinal drawing14$505$20
Photography of content of eyes20$476$12

2014: 9 services

Original Medicare services billed in 2014
Exam of retinal blood vessels using a special camera after injection of a dye52$15,495$129
Photography of the retina56$6,213$49
Long return visit (40+ min)28$4,360$97
New patient visit (60+ min)21$2,956$141
Examination of eye by ophthalmoscope with retinal drawing43$2,542$20
Return visit (30+ min)27$2,527$74
Established patient complete exam of visual system19$2,072$83
Examination of eye by ophthalmoscope with retinal drawing24$835$21
Photography of content of eyes11$267$13

2013: 7 services

Original Medicare services billed in 2013
Exam of retinal blood vessels using a special camera after injection of a dye43$8,669$99
Established patient complete exam of visual system38$3,055$78
Photography of the retina52$3,040$47
Long return visit (40+ min)17$2,243$93
Examination of eye by ophthalmoscope with retinal drawing50$2,081$21
Examination of eye by ophthalmoscope with retinal drawing17$608$22
Imaging of retina17$385$19

Medicaid work

$9,636 in 2024

Medicaid paid $9,636 for 147 billed services this clinician did in 2024, up to 21 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)113$8,704
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI12$488
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina22$444
Medicaid work by year
2024147321$9,636
2023419534$17,898
2022389425$13,155
2021641430$21,227
2020479422$16,180
2019132319$7,134
201845217$1,583
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)222$13,082
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina109$2,140
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI47$1,864
Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral29$616
Bilateral extended ophthalmoscopy with drawing of optic nerve, with interpretation and report12$196

2022

Largest Medicaid services in 2022
Long return visit (40+ min)134$8,186
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina153$2,949
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI32$1,255
Bilateral extended ophthalmoscopy with drawing of optic nerve, with interpretation and report70$765

2021

Largest Medicaid services in 2021
Long return visit (40+ min)224$12,934
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina257$4,622
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI65$2,709
Bilateral extended ophthalmoscopy with drawing of optic nerve, with interpretation and report95$962

2020

Largest Medicaid services in 2020
Long return visit (40+ min)194$10,901
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina170$3,253
Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral99$1,903
Bilateral extended ophthalmoscopy with drawing of optic nerve, with interpretation and report16$124

2019

Largest Medicaid services in 2019
Long return visit (40+ min)80$5,124
Ophthalmoscopy, extended, with retinal drawing (eg, for retinal detachment, melanoma), with interpretation and report; subsequent40$1,706
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina12$304

2018

Largest Medicaid services in 2018
Long return visit (40+ min)18$1,072
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina27$511

Drugs they prescribed that Part D paid

$1,328,244

Pharmacies billed $1,328,244 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 546) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

355 generic and 191 brand-name prescriptions · $1,328,244 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Acthar12$953,219$79,435
Humira(Cf)21$199,767$9,513
Humira16$111,615$6,976
Restasis13$12,051$927
Prednisolone Acetate60$3,264$54
See all 15 drugs
Every Part D drug this clinician prescribed
Acthar12$953,219$79,435
Humira(Cf)21$199,767$9,513
Humira16$111,615$6,976
Restasis13$12,051$927
Prednisolone Acetate60$3,264$54
Mycophenolate Mofetil27$3,022$112
Ketorolac Tromethamine76$1,910$25
Acetazolamide24$1,864$78
Methotrexate16$971$61
Fluorometholone11$816$74
Prednisone63$803$13
Dorzolamide-Timolol36$564$16
Brimonidine29$352$12
Latanoprost25$212$8
Timolol Maleate15$209$14

Year by year

Part D prescribing by year
2024546960% (0)35%$1,328,244
2023576960% (0)37%$1,516,460
20225621030% (0)28%$607,085
2021633990% (0)37%$1,069,482
2020620940% (0)39%$795,537
2019481690% (0)36%$680,174
2018326570% (0)33%$312,044
2017107270% (0)22%$8,019
2016280390% (0)39%$20,226
2015328430% (0)35%$22,500
2014161310% (0)None$9,040
2013134390% (0)33%$11,361

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 16 drugs

Part D drugs prescribed in 2023
Acthar21$1,008,894$48,043
Humira(Cf)28$231,789$8,278
Humira23$201,269$8,751
Restasis12$8,946$745
Prednisolone Acetate62$3,583$58
Alphagan P13$3,097$238
Mycophenolate Mofetil15$2,252$150
Ketorolac Tromethamine67$2,033$30
Prednisone125$1,997$16
Methotrexate20$1,196$60
Dorzolamide-Timolol27$782$29
Timolol Maleate14$412$29
Latanoprost24$370$15
Brimonidine20$241$12
Erythromycin15$186$12
Naproxen11$91$8

2022: 12 drugs

Part D drugs prescribed in 2022
Humira17$101,127$5,949
Humira(Cf)12$90,002$7,500
Humira(Cf)11$76,149$6,923
Restasis17$14,213$836
Mycophenolate Mofetil22$4,183$190
Prednisolone Acetate49$3,082$63
Prednisone134$3,023$23
Methotrexate28$1,670$60
Ketorolac Tromethamine53$1,583$30
Dorzolamide-Timolol31$1,146$37
Timolol Maleate23$253$11
Latanoprost15$245$16

2021: 18 drugs

Part D drugs prescribed in 2021
Gammagard LiquidImmune globulin13$395,620$30,432
Humira(Cf)None18$120,943$6,719
Humira(Cf)None11$68,932$6,267
RestasisNone51$39,386$772
DurezolNone11$6,734$612
Prednisolone AcetateNone60$4,762$79
Mycophenolate MofetilNone23$4,051$176
Doxycycline HyclateNone20$3,482$174
Ketorolac TromethamineNone58$2,860$49
PrednisoneNone103$2,332$23
MethotrexateNone25$1,892$76
Dorzolamide-TimololNone38$1,727$45
AcetazolamideNone20$1,558$78
OlopatadineNone11$268$24
LatanoprostNone13$261$20
BrimonidineNone11$188$17
Timolol MaleateNone13$145$11
NaproxenNone12$99$8

2020: 15 drugs

Part D drugs prescribed in 2020
Gammagard LiquidImmune globulin13$382,165$29,397
RestasisNone38$23,373$615
DurezolNone21$9,118$434
Mycophenolate MofetilNone19$5,364$282
Prednisolone AcetateNone62$5,128$83
AcetazolamideNone24$2,991$125
Ketorolac TromethamineNone45$2,865$64
PrednisoneNone105$2,251$21
MethotrexateNone18$1,517$84
Dorzolamide-TimololNone29$1,149$40
OlopatadineNone14$857$61
Doxycycline HyclateNone16$610$38
LatanoprostNone14$318$23
OmeprazoleNone22$264$12
Sulfamethoxazole-TrimethoprimNone12$201$17

2019: 15 drugs

Part D drugs prescribed in 2019
Acthar11$458,295$41,663
Humira15$82,591$5,506
Restasis23$10,352$450
Mycophenolate Mofetil29$4,853$167
Combigan18$4,774$265
Prednisolone Acetate47$3,502$75
Prednisone108$2,030$19
Brimonidine13$1,274$98
Dorzolamide-Timolol28$1,111$40
Doxycycline Hyclate19$1,000$53
Ketorolac Tromethamine13$371$29
Omeprazole20$366$18
Latanoprost14$309$22
Erythromycin12$160$13
Timolol Maleate17$136$8

2018: 7 drugs

Part D drugs prescribed in 2018
Restasis20$7,469$373
Mycophenolate Mofetil26$3,272$126
Prednisolone Acetate30$1,998$67
Prednisone68$1,792$26
Ketorolac Tromethamine18$710$39
Acyclovir16$416$26
Timolol Maleate11$58$5

2017: 3 drugs

Part D drugs prescribed in 2017
Valacyclovir17$896$53
Methotrexate11$832$76
Prednisone22$759$35

2016: 9 drugs

Part D drugs prescribed in 2016
Valacyclovir33$2,859$87
Durezol18$2,802$156
Prednisolone Acetate38$1,962$52
Methotrexate20$1,442$72
Mycophenolate Mofetil16$1,080$68
Prednisone32$763$24
Diclofenac16$280$18
Latanoprost16$167$10
Timolol Maleate11$88$8

2015: 10 drugs

Part D drugs prescribed in 2015
Prolensa14$3,608$258
Valacyclovir39$3,524$90
Durezol17$2,888$170
Prednisolone Acetate44$2,876$65
Prednisone38$787$21
Ketorolac Tromethamine16$663$41
Methotrexate11$638$58
Diclofenac22$516$23
Latanoprost20$169$8
Acyclovir12$104$9

2014: 4 drugs

Part D drugs prescribed in 2014
Prednisolone Acetate31$2,027$65
Prednisone18$373$21
Ketorolac Tromethamine11$246$22
Diclofenac12$136$11

2013: 4 drugs

Part D drugs prescribed in 2013
Mycophenolate Mofetil20$2,333$117
Ketorolac Tromethamine17$795$47
Prednisolone Acetate23$757$33
Prednisone13$297$23

Money from drug and device companies

$141,789 in 2025

Industry payments by year
202513117$103,210$141,789
202416103$71,345$95,699
20231596$56,559$76,344
20221787$74,024$121,219
2021851$84,510$85,214
20201251$115,818$140,817
20191255$45,343$70,572

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Mallinckrodt Hospital ProductsActhar$85,436
57 payments
  • Meals for Acthar · 2025-12-19 · $11
  • Meals for Acthar · 2025-12-19 · $1
  • Meals for Acthar · 2025-12-19 · $12
  • Meals for Acthar · 2025-12-18 · $14
  • Meals for Acthar · 2025-12-08 · $39
  • Meals for Acthar · 2025-11-17 · $2
  • Meals for Acthar · 2025-11-16 · $38
  • Paid to speak or teach for Acthar · 2025-11-04 · $11,040
  • Paid to speak or teach for Acthar · 2025-11-04 · $5,520
  • Travel for Acthar · 2025-10-30 · $156
  • Travel for Acthar · 2025-10-29 · $1,242
  • Travel for Acthar · 2025-10-28 · $507
  • Travel for Acthar · 2025-10-28 · $1,039
  • Meals for Acthar · 2025-10-28 · $146
  • Meals for Acthar · 2025-10-13 · $35
  • Meals for Acthar · 2025-09-29 · $40
  • Meals for Acthar · 2025-08-26 · $39
  • Meals for Acthar · 2025-08-20 · $32
  • Travel for Acthar · 2025-08-05 · $184
  • Meals for Acthar · 2025-08-05 · $22
  • Meals for Acthar · 2025-07-30 · $86
  • Paid to speak or teach for Acthar · 2025-07-24 · $13,800
  • Meals for Acthar · 2025-07-23 · $28
  • Travel for Acthar · 2025-07-17 · $727
  • Meals for Acthar · 2025-07-17 · $127
  • Paid to speak or teach for Acthar · 2025-06-17 · $7,360
  • Travel for Acthar · 2025-06-12 · $962
  • Meals for Acthar · 2025-06-12 · $105
  • Meals for Acthar · 2025-06-10 · $37
  • Meals for Acthar · 2025-06-04 · $80
  • Travel for Acthar · 2025-06-04 · $168
  • Meals for Acthar · 2025-06-04 · $20
  • Meals for Acthar · 2025-06-04 · $29
  • Paid to speak or teach for Acthar · 2025-05-29 · $13,800
  • Travel for Acthar · 2025-05-23 · $216
  • Meals for Acthar · 2025-05-22 · $143
  • Travel for Acthar · 2025-05-22 · $1,655
  • Meals for Acthar · 2025-05-15 · $37
  • Meals for Acthar · 2025-05-14 · $135
  • Travel for Acthar · 2025-04-22 · $116
  • Meals for Acthar · 2025-04-22 · $16
  • Meals for Acthar · 2025-04-22 · $40
  • Travel for Acthar · 2025-04-22 · $21
  • Meals for Acthar · 2025-04-22 · $20
  • Paid to speak or teach for Acthar · 2025-04-17 · $12,880
  • Meals for Acthar · 2025-04-16 · $39
  • Travel for Acthar · 2025-04-12 · $205
  • Meals for Acthar · 2025-04-10 · $129
  • Travel for Acthar · 2025-04-10 · $654
  • Travel for Acthar · 2025-04-10 · $841
  • Meals for Acthar · 2025-04-10 · $17
  • Meals for Acthar · 2025-03-06 · $33
  • Meals for Acthar · 2025-03-04 · $38
  • Paid to speak or teach for Acthar · 2025-02-11 · $9,200
  • Travel for Acthar · 2025-02-06 · $1,399
  • Meals for Acthar · 2025-02-06 · $120
  • Meals for Acthar · 2025-02-03 · $35
Regeneron PharmaceuticalsEylea Hd$26,047
16 payments
  • Travel for Eylea Hd · 2025-10-28 · $12,849
  • Travel for Eylea Hd · 2025-10-28 · $26
  • Travel for Eylea Hd · 2025-09-16 · $261
  • Travel for Eylea Hd · 2025-09-16 · $219
  • Meals · 2025-09-12 · $47
  • Meals for Eylea Hd · 2025-09-10 · $150
  • Travel for Eylea Hd · 2025-09-09 · $180
  • Meals for Eylea Hd · 2025-07-31 · $26
  • Travel for Eylea Hd · 2025-07-23 · $9,729
  • Travel for Eylea Hd · 2025-07-23 · $1,175
  • Travel for Eylea Hd · 2025-07-23 · $26
  • Travel for Eylea Hd · 2025-07-23 · $26
  • Meals for Eylea Hd · 2025-05-05 · $47
  • Consulting for Eylea · 2025-04-18 · $1,105
  • Meals for Eylea Hd · 2025-03-22 · $92
  • Meals for Eylea Hd · 2025-01-21 · $91
Boehringer Ingelheim International GmbHNone$16,350
4 payments
  • Consulting · 2025-05-20 · $6,175
  • Consulting · 2025-05-20 · $6,175
  • Consulting · 2025-05-19 · $2,000
  • Consulting · 2025-05-19 · $2,000
Genentech USANone$3,565
2 payments
  • Consulting · 2025-07-31 · $3,445
  • Meals · 2025-07-31 · $120
Harrow EyeVevye$2,937
2 payments
  • Consulting for Vevye · 2025-03-20 · $2,800
  • Meals for Triesence · 2025-01-23 · $137
Alcon VisionNone$2,500
2 payments
  • Consulting · 2025-10-23 · $500
  • Consulting · 2025-09-18 · $2,000
See all 117 published payments
Every published payment
Mallinckrodt Hospital ProductsMeals · 2025-12-19Acthar$11
Mallinckrodt Hospital ProductsMeals · 2025-12-19Acthar$1
Mallinckrodt Hospital ProductsMeals · 2025-12-19Acthar$12
Mallinckrodt Hospital ProductsMeals · 2025-12-18Acthar$14
AmgenMeals · 2025-12-16Tavneos$143
Mallinckrodt Hospital ProductsMeals · 2025-12-08Acthar$39
Mallinckrodt Hospital ProductsMeals · 2025-11-17Acthar$2
Mallinckrodt Hospital ProductsMeals · 2025-11-16Acthar$38
Apellis PharmaceuticalsMeals · 2025-11-12Syfovre$26
Astellas Pharma USMeals · 2025-11-11Izervay$91
ANI PharmaceuticalsMeals · 2025-11-10Iluvien$29
Mallinckrodt Hospital ProductsPaid to speak or teach · 2025-11-04Acthar$11,040
Mallinckrodt Hospital ProductsPaid to speak or teach · 2025-11-04Acthar$5,520
Mallinckrodt Hospital ProductsTravel · 2025-10-30Acthar$156
Mallinckrodt Hospital ProductsTravel · 2025-10-29Acthar$1,242
Mallinckrodt Hospital ProductsTravel · 2025-10-28Acthar$507
Mallinckrodt Hospital ProductsTravel · 2025-10-28Acthar$1,039
Mallinckrodt Hospital ProductsMeals · 2025-10-28Acthar$146
Regeneron PharmaceuticalsTravel · 2025-10-28Eylea Hd$12,849
Regeneron PharmaceuticalsTravel · 2025-10-28Eylea Hd$26
Alcon VisionConsulting · 2025-10-23None$500
Astellas Pharma Global DevelopmentMeals · 2025-10-21Izervay$33
Astellas Pharma Global DevelopmentMeals · 2025-10-19Izervay$137
Mallinckrodt Hospital ProductsMeals · 2025-10-13Acthar$35
Bausch & Lomb AmericasMeals · 2025-10-13Xipere$111
Apellis PharmaceuticalsMeals · 2025-10-07Syfovre$4
Apellis PharmaceuticalsMeals · 2025-10-06Syfovre$28
ANI PharmaceuticalsMeals · 2025-10-01Purified Cortrophin Gel$23
ANI PharmaceuticalsMeals · 2025-10-01Iluvien$4
Mallinckrodt Hospital ProductsMeals · 2025-09-29Acthar$40
Alcon VisionConsulting · 2025-09-18None$2,000
Regeneron PharmaceuticalsTravel · 2025-09-16Eylea Hd$261
Regeneron PharmaceuticalsTravel · 2025-09-16Eylea Hd$219
Regeneron PharmaceuticalsMeals · 2025-09-12None$47
Regeneron PharmaceuticalsMeals · 2025-09-10Eylea Hd$150
Regeneron PharmaceuticalsTravel · 2025-09-09Eylea Hd$180
Mallinckrodt Hospital ProductsMeals · 2025-08-26Acthar$39
ANI PharmaceuticalsMeals · 2025-08-26Iluvien$31
Bausch & Lomb AmericasMeals · 2025-08-22Xipere$108
Mallinckrodt Hospital ProductsMeals · 2025-08-20Acthar$32
Apellis PharmaceuticalsMeals · 2025-08-14Syfovre$4
Apellis PharmaceuticalsMeals · 2025-08-13Syfovre$25
Mallinckrodt Hospital ProductsTravel · 2025-08-05Acthar$184
Mallinckrodt Hospital ProductsMeals · 2025-08-05Acthar$22
ANI PharmaceuticalsMeals · 2025-08-04Iluvien$30
Astellas Pharma Global DevelopmentMeals · 2025-08-02Izervay$110
Genentech USAConsulting · 2025-07-31None$3,445
Genentech USAMeals · 2025-07-31None$120
Regeneron PharmaceuticalsMeals · 2025-07-31Eylea Hd$26
Apellis PharmaceuticalsMeals · 2025-07-31Syfovre$29
Mallinckrodt Hospital ProductsMeals · 2025-07-30Acthar$86
Mallinckrodt Hospital ProductsPaid to speak or teach · 2025-07-24Acthar$13,800
Mallinckrodt Hospital ProductsMeals · 2025-07-23Acthar$28
Regeneron PharmaceuticalsTravel · 2025-07-23Eylea Hd$9,729
Regeneron PharmaceuticalsTravel · 2025-07-23Eylea Hd$1,175
Regeneron PharmaceuticalsTravel · 2025-07-23Eylea Hd$26
Regeneron PharmaceuticalsTravel · 2025-07-23Eylea Hd$26
Mallinckrodt Hospital ProductsTravel · 2025-07-17Acthar$727
Mallinckrodt Hospital ProductsMeals · 2025-07-17Acthar$127
Apellis PharmaceuticalsMeals · 2025-07-09Syfovre$20
ANI PharmaceuticalsMeals · 2025-07-02Yutiq$27
Bausch & Lomb AmericasConsulting · 2025-06-24None$2,000
ANI PharmaceuticalsMeals · 2025-06-19Yutiq$34
Apellis PharmaceuticalsMeals · 2025-06-18Syfovre$13
Mallinckrodt Hospital ProductsPaid to speak or teach · 2025-06-17Acthar$7,360
Mallinckrodt Hospital ProductsTravel · 2025-06-12Acthar$962
Mallinckrodt Hospital ProductsMeals · 2025-06-12Acthar$105
Mallinckrodt Hospital ProductsMeals · 2025-06-10Acthar$37
Apellis PharmaceuticalsMeals · 2025-06-05Syfovre$138
Mallinckrodt Hospital ProductsMeals · 2025-06-04Acthar$80
Mallinckrodt Hospital ProductsTravel · 2025-06-04Acthar$168
Mallinckrodt Hospital ProductsMeals · 2025-06-04Acthar$20
Mallinckrodt Hospital ProductsMeals · 2025-06-04Acthar$29
ANI PharmaceuticalsMeals · 2025-06-04Yutiq$31
Mallinckrodt Hospital ProductsPaid to speak or teach · 2025-05-29Acthar$13,800
Mallinckrodt Hospital ProductsTravel · 2025-05-23Acthar$216
Mallinckrodt Hospital ProductsMeals · 2025-05-22Acthar$143
Mallinckrodt Hospital ProductsTravel · 2025-05-22Acthar$1,655
Boehringer Ingelheim International GmbHConsulting · 2025-05-20None$6,175
Boehringer Ingelheim International GmbHConsulting · 2025-05-20None$6,175
Boehringer Ingelheim International GmbHConsulting · 2025-05-19None$2,000
Boehringer Ingelheim International GmbHConsulting · 2025-05-19None$2,000
Mallinckrodt Hospital ProductsMeals · 2025-05-15Acthar$37
Mallinckrodt Hospital ProductsMeals · 2025-05-14Acthar$135
ANI PharmaceuticalsMeals · 2025-05-12Yutiq$30
Astellas Pharma Global DevelopmentMeals · 2025-05-06Izervay$24
Astellas Pharma USMeals · 2025-05-06Izervay$22
Regeneron PharmaceuticalsMeals · 2025-05-05Eylea Hd$47
Merck Sharp & DohmeConsulting · 2025-05-05None$1,410
Apellis PharmaceuticalsMeals · 2025-04-29Syfovre$31
Mallinckrodt Hospital ProductsTravel · 2025-04-22Acthar$116
Mallinckrodt Hospital ProductsMeals · 2025-04-22Acthar$16
Mallinckrodt Hospital ProductsMeals · 2025-04-22Acthar$40
Mallinckrodt Hospital ProductsTravel · 2025-04-22Acthar$21
Mallinckrodt Hospital ProductsMeals · 2025-04-22Acthar$20
Regeneron PharmaceuticalsConsulting · 2025-04-18Eylea$1,105
Mallinckrodt Hospital ProductsPaid to speak or teach · 2025-04-17Acthar$12,880
Mallinckrodt Hospital ProductsMeals · 2025-04-16Acthar$39
Mallinckrodt Hospital ProductsTravel · 2025-04-12Acthar$205
Mallinckrodt Hospital ProductsMeals · 2025-04-10Acthar$129
Mallinckrodt Hospital ProductsTravel · 2025-04-10Acthar$654
Mallinckrodt Hospital ProductsTravel · 2025-04-10Acthar$841
Mallinckrodt Hospital ProductsMeals · 2025-04-10Acthar$17
ANI PharmaceuticalsMeals · 2025-04-07Yutiq$27
Regeneron PharmaceuticalsMeals · 2025-03-22Eylea Hd$92
Harrow EyeConsulting · 2025-03-20Vevye$2,800
Bausch & Lomb AmericasMeals · 2025-03-20Miebo$129
Mallinckrodt Hospital ProductsMeals · 2025-03-06Acthar$33
Mallinckrodt Hospital ProductsMeals · 2025-03-04Acthar$38
Astellas Pharma USMeals · 2025-02-27Izervay$29
Mallinckrodt Hospital ProductsPaid to speak or teach · 2025-02-11Acthar$9,200
Mallinckrodt Hospital ProductsTravel · 2025-02-06Acthar$1,399
Mallinckrodt Hospital ProductsMeals · 2025-02-06Acthar$120
Mallinckrodt Hospital ProductsMeals · 2025-02-03Acthar$35
Apellis PharmaceuticalsMeals · 2025-01-28Syfovre$27
Harrow EyeMeals · 2025-01-23Triesence$137
Regeneron PharmaceuticalsMeals · 2025-01-21Eylea Hd$91
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $95,699

Payments by company in 2024
Mallinckrodt Hospital ProductsActhar$50,558
29 payments
  • Meals for Acthar · 2024-12-21 · $36
  • Meals for Acthar · 2024-11-12 · $177
  • Meals for Acthar · 2024-11-07 · $35
  • Meals for Acthar · 2024-10-15 · $36
  • Meals for Acthar · 2024-09-24 · $149
  • Meals for Acthar · 2024-09-05 · $39
  • Meals for Acthar · 2024-08-28 · $3
  • Meals for Acthar · 2024-08-27 · $33
  • Meals for Acthar · 2024-08-20 · $38
  • Paid to speak or teach for Acthar · 2024-08-13 · $2,695
  • Paid to speak or teach for Acthar · 2024-08-06 · $3,590
  • Paid to speak or teach for Acthar · 2024-06-21 · $4,490
  • Meals for Acthar · 2024-06-18 · $39
  • Meals for Acthar · 2024-05-07 · $42
  • Meals for Acthar · 2024-04-11 · $12
  • Travel for Acthar · 2024-04-11 · $133
  • Paid to speak or teach for Acthar · 2024-03-19 · $3,590
  • Paid to speak or teach for Acthar · 2024-03-14 · $3,590
  • Paid to speak or teach for Acthar · 2024-02-27 · $4,490
  • Paid to speak or teach for Acthar · 2024-02-22 · $12,565
  • Travel for Acthar · 2024-02-15 · $733
  • Travel for Acthar · 2024-02-15 · $499
  • Meals for Acthar · 2024-02-15 · $147
  • Travel for Acthar · 2024-02-15 · $1,852
  • Travel for Acthar · 2024-02-15 · $605
  • Meals for Acthar · 2024-02-15 · $22
  • Paid to speak or teach for Acthar · 2024-02-13 · $3,590
  • Paid to speak or teach for Acthar · 2024-02-01 · $7,180
  • Meals for Acthar · 2024-01-25 · $146
Apellis PharmaceuticalsSyfovre$14,763
20 payments
  • Meals for Syfovre · 2024-11-04 · $25
  • Meals for Syfovre · 2024-10-08 · $18
  • Meals for Syfovre · 2024-07-11 · $4
  • Meals for Syfovre · 2024-06-05 · $27
  • Meals for Syfovre · 2024-05-15 · $29
  • Meals for Syfovre · 2024-04-29 · $27
  • Meals for Syfovre · 2024-04-29 · $23
  • Meals for Syfovre · 2024-04-26 · $1
  • Meals for Syfovre · 2024-04-26 · $1
  • Meals for Syfovre · 2024-04-08 · $19
  • Meals for Syfovre · 2024-03-14 · $20
  • Meals for Syfovre · 2024-02-27 · $123
  • Travel for Syfovre · 2024-02-27 · $648
  • Meals for Syfovre · 2024-02-26 · $189
  • Travel for Syfovre · 2024-02-26 · $325
  • Paid to speak or teach for Syfovre · 2024-02-26 · $12,489
  • Meals for Syfovre · 2024-02-25 · $71
  • Travel for Syfovre · 2024-02-25 · $82
  • Travel for Syfovre · 2024-02-25 · $586
  • Meals for Syfovre · 2024-01-16 · $56
Boehringer Ingelheim PharmaceuticalsNone$13,191
2 payments
  • Travel · 2024-12-03 · $2,415
  • Travel · 2024-12-03 · $10,776
Merck Sharp & DohmeNone$9,887
10 payments
  • Travel · 2024-10-23 · $150
  • Consulting · 2024-10-23 · $7,755
  • Meals · 2024-10-09 · $55
  • Meals · 2024-10-09 · $65
  • Travel · 2024-10-09 · $345
  • Meals · 2024-10-09 · $60
  • Travel · 2024-10-08 · $151
  • Travel · 2024-10-08 · $345
  • Travel · 2024-10-08 · $811
  • Travel · 2024-10-08 · $151
Ocular TherapeutixDextenza$2,289
3 payments
  • Consulting · 2024-06-14 · $2,000
  • Meals for Dextenza · 2024-01-17 · $156
  • Meals for Dextenza · 2024-01-15 · $133
Boehringer Ingelheim International GmbHNone$2,216
6 payments
  • Paid to speak or teach · 2024-07-12 · $578
  • Paid to speak or teach · 2024-07-10 · $190
  • Paid to speak or teach · 2024-07-10 · $233
  • Paid to speak or teach · 2024-07-10 · $441
  • Paid to speak or teach · 2024-07-10 · $513
  • Paid to speak or teach · 2024-04-12 · $262
Regeneron PharmaceuticalsEylea$1,483
5 payments
  • Meals for Eylea · 2024-09-11 · $86
  • Meals for Eylea · 2024-07-19 · $94
  • Consulting for Eylea · 2024-07-12 · $1,105
  • Meals for Eylea · 2024-05-09 · $131
  • Meals for Eylea Hd · 2024-01-14 · $67
Astellas Pharma USIzervay$421
9 payments
  • Meals for Izervay · 2024-10-23 · $32
  • Meals for Izervay · 2024-10-17 · $106
  • Meals for Izervay · 2024-09-26 · $33
  • Meals for Izervay · 2024-08-27 · $18
  • Meals for Izervay · 2024-08-27 · $11
  • Meals for Izervay · 2024-06-27 · $31
  • Meals for Izervay · 2024-06-25 · $131
  • Meals for Izervay · 2024-04-24 · $33
  • Meals for Izervay · 2024-03-28 · $26
Bausch & Lomb AmericasXipere$228
2 payments
  • Meals for Xipere · 2024-05-03 · $139
  • Meals for Vyzulta · 2024-03-10 · $88
ANI PharmaceuticalsPurified Cortrophin Gel$205
9 payments
  • Meals for Purified Cortrophin Gel · 2024-10-25 · $30
  • Meals for Purified Cortrophin Gel · 2024-07-12 · $31
  • Meals for Purified Cortrophin Gel · 2024-05-02 · $22
  • Meals for Purified Cortrophin Gel · 2024-04-16 · $2
  • Meals for Purified Cortrophin Gel · 2024-04-16 · $22
  • Meals for Purified Cortrophin Gel · 2024-03-12 · $20
  • Meals for Purified Cortrophin Gel · 2024-02-06 · $23
  • Meals for Purified Cortrophin Gel · 2024-01-26 · $32
  • Meals for Purified Cortrophin Gel · 2024-01-09 · $23
AbbvieOzurdex$123
1 payment
  • Meals for Ozurdex · 2024-01-18 · $123
Astellas Pharma Global DevelopmentIzervay$103
2 payments
  • Meals for Izervay · 2024-10-21 · $58
  • Meals for Izervay · 2024-05-09 · $45
AmgenPavblu$85
1 payment
  • Meals for Pavblu · 2024-07-23 · $85
GenentechNone$67
2 payments
  • Meals · 2024-07-20 · $20
  • Meals · 2024-05-06 · $47
Janssen PharmaceuticalsNone$50
1 payment
  • Meals · 2024-07-19 · $50
Thea PharmaIyuzeh$29
1 payment
  • Meals for Iyuzeh · 2024-02-23 · $29

2023: $76,344

Payments by company in 2023
Horizon Therapeutics plcNone$21,000
1 payment
  • Consulting · 2023-01-13 · $21,000
Bausch & Lomb AmericasXipere$16,811
9 payments
  • Meals for Miebo · 2023-12-06 · $45
  • Meals for Miebo · 2023-11-27 · $118
  • Meals for Xipere · 2023-08-21 · $116
  • Meals for Xipere · 2023-07-31 · $123
  • Meals for Xipere · 2023-05-04 · $31
  • Meals · 2023-04-20 · $140
  • Paid to speak or teach for Xipere · 2023-03-29 · $825
  • Paid to speak or teach for Xipere · 2023-03-08 · $413
  • Grant · 2023-02-28 · $15,000
Boehringer Ingelheim International GmbHNone$15,491
16 payments
  • Paid to speak or teach · 2023-12-30 · $660
  • Paid to speak or teach · 2023-12-30 · $578
  • Paid to speak or teach · 2023-12-30 · $4,621
  • Travel · 2023-12-30 · $111
  • Paid to speak or teach · 2023-10-03 · $578
  • Paid to speak or teach · 2023-10-03 · $1,890
  • Paid to speak or teach · 2023-08-01 · $262
  • Paid to speak or teach · 2023-08-01 · $262
  • Paid to speak or teach · 2023-08-01 · $299
  • Paid to speak or teach · 2023-08-01 · $660
  • Paid to speak or teach · 2023-08-01 · $299
  • Paid to speak or teach · 2023-08-01 · $262
  • Paid to speak or teach · 2023-08-01 · $606
  • Consulting · 2023-05-16 · $2,550
  • Paid to speak or teach · 2023-01-17 · $927
  • Paid to speak or teach · 2023-01-17 · $927
Mallinckrodt Hospital ProductsActhar$15,297
27 payments
  • Meals for Acthar · 2023-12-22 · $5
  • Meals for Acthar · 2023-12-21 · $16
  • Meals for Acthar · 2023-12-21 · $14
  • Meals for Acthar · 2023-12-19 · $22
  • Paid to speak or teach for Acthar · 2023-12-05 · $4,490
  • Meals for Acthar · 2023-11-14 · $37
  • Meals for Acthar · 2023-10-31 · $3
  • Meals for Acthar · 2023-10-31 · $23
  • Meals for Acthar · 2023-10-19 · $20
  • Meals for Acthar · 2023-10-19 · $3
  • Meals for Acthar · 2023-09-26 · $40
  • Meals for Acthar · 2023-09-21 · $39
  • Meals for Acthar · 2023-08-29 · $35
  • Travel for Acthar · 2023-08-01 · $40
  • Paid to speak or teach for Acthar · 2023-07-25 · $8,975
  • Meals for Acthar · 2023-07-20 · $29
  • Meals for Acthar · 2023-06-22 · $23
  • Meals for Acthar · 2023-06-08 · $149
  • Travel for Acthar · 2023-06-08 · $400
  • Travel for Acthar · 2023-06-08 · $281
  • Travel for Acthar · 2023-06-08 · $428
  • Meals for Acthar · 2023-06-06 · $33
  • Meals for Acthar · 2023-03-29 · $31
  • Meals for Acthar · 2023-03-28 · $9
  • Meals for Acthar · 2023-03-18 · $100
  • Meals for Acthar · 2023-01-25 · $40
  • Meals for Acthar · 2023-01-19 · $14
Regeneron PharmaceuticalsEylea$4,671
7 payments
  • Meals for Eylea Hd · 2023-11-29 · $87
  • Meals for Eylea Hd · 2023-11-17 · $135
  • Meals for Eylea · 2023-07-30 · $39
  • Consulting for Eylea · 2023-03-24 · $1,058
  • Consulting for Eylea · 2023-03-24 · $3,174
  • Meals for Eylea · 2023-03-17 · $115
  • Meals for Eylea · 2023-03-13 · $63
Boehringer Ingelheim PharmaceuticalsNone$1,245
2 payments
  • Paid to speak or teach · 2023-03-16 · $847
  • Paid to speak or teach · 2023-01-23 · $398
BiogenNone$369
9 payments
  • Meals · 2023-08-09 · $16
  • Meals · 2023-07-11 · $18
  • Meals · 2023-06-14 · $14
  • Meals · 2023-05-11 · $13
  • Meals · 2023-04-12 · $11
  • Meals · 2023-03-24 · $1
  • Meals · 2023-03-24 · $29
  • Meals · 2023-03-09 · $140
  • Meals · 2023-01-25 · $128
GenentechLucentis$309
2 payments
  • Meals for Lucentis · 2023-04-26 · $189
  • Meals for Vabysmo · 2023-03-23 · $120
Apellis PharmaceuticalsSyfovre$307
6 payments
  • Meals for Syfovre · 2023-12-05 · $1
  • Meals for Syfovre · 2023-12-05 · $16
  • Meals for Syfovre · 2023-12-05 · $1
  • Meals for Syfovre · 2023-09-20 · $125
  • Meals for Syfovre · 2023-04-18 · $132
  • Meals for Syfovre · 2023-03-08 · $32
Astellas Pharma USNone$294
4 payments
  • Meals · 2023-10-25 · $15
  • Meals · 2023-09-11 · $31
  • Meals · 2023-09-05 · $98
  • Meals · 2023-08-02 · $149
Alimera SciencesIluvien$243
2 payments
  • Meals for Yutiq · 2023-11-07 · $120
  • Meals for Iluvien · 2023-05-31 · $123
ANI PharmaceuticalsPurified Cortrophin Gel$158
7 payments
  • Meals for Purified Cortrophin Gel · 2023-12-12 · $16
  • Meals for Purified Cortrophin Gel · 2023-11-02 · $21
  • Meals for Purified Cortrophin Gel · 2023-10-27 · $28
  • Meals for Purified Cortrophin Gel · 2023-09-12 · $12
  • Meals for Purified Cortrophin Gel · 2023-07-25 · $31
  • Meals for Purified Cortrophin Gel · 2023-07-13 · $15
  • Meals for Purified Cortrophin Gel · 2023-01-20 · $34
Ocular TherapeutixDextenza$90
1 payment
  • Meals for Dextenza · 2023-07-30 · $90
Janssen Research & DevelopmentWhitestar Phaco Handpiece$45
2 payments
  • Meals for Whitestar Phaco Handpiece · 2023-06-09 · $20
  • Meals for Whitestar Phaco Handpiece · 2023-05-20 · $25
Genentech USAVabysmo$14
1 payment
  • Meals for Vabysmo · 2023-03-29 · $14

2022: $121,219

Payments by company in 2022
Bausch & Lomb AmericasXipere$50,052
10 payments
  • Paid to speak or teach for Xipere · 2022-12-14 · $1,000
  • Grant · 2022-11-03 · $12,900
  • Paid to speak or teach for Xipere · 2022-10-26 · $1,000
  • Paid to speak or teach for Xipere · 2022-09-29 · $1,035
  • Consulting for Xipere · 2022-06-02 · $1,200
  • Consulting for Xipere · 2022-04-20 · $1,200
  • Meals for Xipere · 2022-04-14 · $117
  • Consulting for Xipere · 2022-04-13 · $1,200
  • Grant · 2022-03-02 · $25,000
  • Consulting for Xipere · 2022-02-28 · $5,400
Mallinckrodt Hospital ProductsActhar$37,286
27 payments
  • Meals for Acthar · 2022-12-21 · $30
  • Meals for Acthar · 2022-12-20 · $3
  • Paid to speak or teach for Acthar · 2022-10-20 · $7,180
  • Meals for Acthar · 2022-10-13 · $115
  • Meals for Acthar · 2022-09-20 · $32
  • Meals for Acthar · 2022-08-30 · $12
  • Meals for Acthar · 2022-08-29 · $1
  • Meals for Acthar · 2022-08-17 · $112
  • Meals for Acthar · 2022-08-13 · $10
  • Meals for Acthar · 2022-08-12 · $2
  • Meals for Acthar · 2022-08-12 · $34
  • Meals for Acthar · 2022-07-22 · $12
  • Paid to speak or teach for Acthar · 2022-07-14 · $3,590
  • Meals for Acthar · 2022-07-08 · $25
  • Paid to speak or teach for Acthar · 2022-06-23 · $3,590
  • Paid to speak or teach for Acthar · 2022-06-07 · $8,080
  • Meals for Acthar · 2022-05-25 · $31
  • Paid to speak or teach for Acthar · 2022-05-24 · $10,770
  • Travel for Acthar · 2022-05-20 · $1,455
  • Meals for Acthar · 2022-05-20 · $44
  • Travel for Acthar · 2022-05-20 · $550
  • Travel for Acthar · 2022-05-19 · $359
  • Meals for Acthar · 2022-05-19 · $84
  • Travel for Acthar · 2022-05-19 · $1,019
  • Meals for Acthar · 2022-03-24 · $92
  • Meals for Acthar · 2022-03-01 · $34
  • Meals for Acthar · 2022-01-12 · $20
Exeltis USAPurified Cortrophin Gel$11,108
13 payments
  • Meals for Purified Cortrophin Gel · 2022-11-11 · $7
  • Meals for Purified Cortrophin Gel · 2022-11-02 · $8
  • Meals for Purified Cortrophin Gel · 2022-11-01 · $25
  • Meals for Purified Cortrophin Gel · 2022-10-19 · $8
  • Meals for Purified Cortrophin Gel · 2022-10-04 · $13
  • Meals for Purified Cortrophin Gel · 2022-10-04 · $25
  • Meals for Purified Cortrophin Gel · 2022-09-16 · $11
  • Meals for Purified Cortrophin Gel · 2022-08-22 · $8
  • Meals for Purified Cortrophin Gel · 2022-06-08 · $56
  • Paid to speak or teach for Purified Cortrophin Gel · 2022-06-08 · $9,425
  • Meals for Purified Cortrophin Gel · 2022-05-31 · $46
  • Travel for Purified Cortrophin Gel · 2022-04-26 · $965
  • Travel for Purified Cortrophin Gel · 2022-04-26 · $511
Merck Sharp & DohmeNone$9,712
11 payments
  • Travel · 2022-06-06 · $150
  • Consulting · 2022-06-06 · $7,425
  • Meals · 2022-05-27 · $35
  • Meals · 2022-05-27 · $50
  • Meals · 2022-05-27 · $50
  • Meals · 2022-05-26 · $16
  • Travel · 2022-05-26 · $174
  • Travel · 2022-05-26 · $197
  • Meals · 2022-05-26 · $125
  • Travel · 2022-05-26 · $1,311
  • Travel · 2022-05-26 · $179
BiogenNone$4,772
3 payments
  • Paid to speak or teach · 2022-10-21 · $4,675
  • Meals · 2022-09-14 · $25
  • Meals · 2022-06-28 · $72
Boehringer Ingelheim International GmbHNone$2,399
6 payments
  • Paid to speak or teach · 2022-11-02 · $564
  • Paid to speak or teach · 2022-06-21 · $398
  • Paid to speak or teach · 2022-05-04 · $341
  • Paid to speak or teach · 2022-05-03 · $564
  • Paid to speak or teach · 2022-01-24 · $266
  • Paid to speak or teach · 2022-01-07 · $266
GenentechVabysmo$2,104
3 payments
  • Meals for Vabysmo · 2022-03-27 · $25
  • Meals for Vabysmo · 2022-03-22 · $120
  • Consulting for Vabysmo · 2022-02-26 · $1,960
Samsung Bioepis Co.None$1,700
1 payment
  • Consulting · 2022-09-01 · $1,700
Regeneron PharmaceuticalsEylea$1,354
3 payments
  • Meals for Eylea · 2022-09-30 · $43
  • Meals for Eylea · 2022-08-24 · $116
  • Consulting for Eylea · 2022-04-08 · $1,195
Spark TherapeuticsNone$155
2 payments
  • Meals · 2022-06-16 · $125
  • Meals · 2022-02-01 · $30
Dutch Ophthalmic USAEva, Combined Machine$149
1 payment
  • Meals for Eva, Combined Machine · 2022-04-15 · $149
AbbvieOzurdex$124
1 payment
  • Meals for Ozurdex · 2022-08-16 · $124
Novartis PharmaceuticalsNone$85
1 payment
  • Meals · 2022-03-23 · $85
Alimera SciencesIluvien$66
1 payment
  • Meals for Iluvien · 2022-05-03 · $66
Coherus BiosciencesCimerli$58
2 payments
  • Meals for Cimerli · 2022-10-31 · $14
  • Meals for Cimerli · 2022-09-27 · $44
Janssen Global ServicesNone$47
1 payment
  • Meals · 2022-11-03 · $47
Apellis PharmaceuticalsNone$47
1 payment
  • Meals · 2022-09-13 · $47

2021: $85,214

Payments by company in 2021
Mallinckrodt Hospital ProductsActhar$52,142
24 payments
  • Paid to speak or teach for Acthar · 2021-11-12 · $7,180
  • Meals for Acthar · 2021-11-04 · $122
  • Meals for Acthar · 2021-10-27 · $26
  • Meals for Acthar · 2021-10-07 · $125
  • Meals for Acthar · 2021-10-06 · $2
  • Meals for Acthar · 2021-10-05 · $23
  • Paid to speak or teach for Acthar · 2021-09-28 · $4,490
  • Paid to speak or teach for Acthar · 2021-09-28 · $3,590
  • Paid to speak or teach for Acthar · 2021-09-09 · $4,490
  • Paid to speak or teach for Acthar · 2021-08-24 · $3,590
  • Paid to speak or teach for Acthar · 2021-08-17 · $3,590
  • Meals for Acthar · 2021-07-28 · $2
  • Meals for Acthar · 2021-07-21 · $21
  • Paid to speak or teach for Acthar · 2021-06-29 · $3,590
  • Meals for Acthar · 2021-06-15 · $32
  • Paid to speak or teach for Acthar · 2021-05-25 · $3,590
  • Paid to speak or teach for Acthar · 2021-04-15 · $3,590
  • Paid to speak or teach for Acthar · 2021-03-30 · $3,590
  • Education for Acthar · 2021-03-24 · $93
  • Paid to speak or teach for Acthar · 2021-03-23 · $3,590
  • Paid to speak or teach for Acthar · 2021-03-16 · $3,590
  • Meals for Acthar · 2021-01-27 · $34
  • Education for Acthar · 2021-01-27 · $93
  • Paid to speak or teach for Acthar · 2021-01-12 · $3,100
Boehringer Ingelheim International GmbHNone$8,491
16 payments
  • Paid to speak or teach · 2021-12-11 · $927
  • Paid to speak or teach · 2021-11-12 · $327
  • Paid to speak or teach · 2021-09-24 · $327
  • Paid to speak or teach · 2021-09-14 · $398
  • Paid to speak or teach · 2021-09-09 · $618
  • Paid to speak or teach · 2021-07-17 · $137
  • Paid to speak or teach · 2021-07-14 · $266
  • Paid to speak or teach · 2021-06-22 · $137
  • Paid to speak or teach · 2021-06-22 · $239
  • Paid to speak or teach · 2021-06-22 · $398
  • Paid to speak or teach · 2021-05-01 · $726
  • Paid to speak or teach · 2021-04-30 · $266
  • Paid to speak or teach · 2021-04-13 · $96
  • Paid to speak or teach · 2021-04-13 · $137
  • Paid to speak or teach · 2021-04-12 · $3,151
  • Paid to speak or teach · 2021-04-09 · $341
Kala PharmaceuticalsEysuvis$7,650
1 payment
  • Consulting for Eysuvis · 2021-04-30 · $7,650
Novartis Pharma AGBeovu$7,524
2 payments
  • Consulting for Beovu · 2021-12-14 · $4,837
  • Consulting for Beovu · 2021-08-17 · $2,687
Bausch & Lomb a division of Bausch Health USVisudyne$3,781
3 payments
  • Consulting for Xipere · 2021-12-03 · $1,500
  • Meals for Xipere · 2021-11-14 · $31
  • Consulting for Visudyne · 2021-01-06 · $2,250
BiogenNone$3,400
1 payment
  • Consulting · 2021-10-22 · $3,400
Samsung Bioepis Co.None$1,275
1 payment
  • Consulting · 2021-03-18 · $1,275
AllerganOzurdex$951
3 payments
  • Meals for Ozurdex · 2021-10-10 · $51
  • Meals for Ozurdex · 2021-10-10 · $51
  • Consulting for Ozurdex · 2021-03-09 · $850

2020: $140,817

Payments by company in 2020
Aerie PharmaceuticalsNone$44,240
5 payments
  • Consulting · 2020-05-06 · $20,540
  • Consulting · 2020-02-28 · $15,800
  • Consulting · 2020-02-28 · $3,950
  • Consulting · 2020-02-28 · $2,370
  • Consulting · 2020-02-28 · $1,580
Bausch & Lomb a division of Bausch Health USXipere$25,791
4 payments
  • Consulting for Xipere · 2020-02-21 · $2,250
  • Travel for Xipere · 2020-02-07 · $416
  • Meals for Xipere · 2020-02-07 · $125
  • Grant · 2020-01-20 · $23,000
Mallinckrodt Hospital ProductsActhar$18,949
16 payments
  • Paid to speak or teach for Acthar · 2020-12-08 · $3,100
  • Paid to speak or teach for Acthar · 2020-12-08 · $3,100
  • Meals for Acthar · 2020-12-02 · $1
  • Meals for Acthar · 2020-12-02 · $24
  • Paid to speak or teach for Acthar · 2020-11-19 · $3,100
  • Paid to speak or teach for Acthar · 2020-11-17 · $3,100
  • Meals for Acthar · 2020-11-05 · $10
  • Meals for Acthar · 2020-10-28 · $1
  • Meals for Acthar · 2020-10-27 · $25
  • Meals for Acthar · 2020-09-23 · $29
  • Paid to speak or teach for Acthar · 2020-09-22 · $3,100
  • Meals for Acthar · 2020-03-11 · $33
  • Paid to speak or teach for Acthar · 2020-02-20 · $3,100
  • Meals for Acthar · 2020-02-13 · $105
  • Meals for Acthar · 2020-01-28 · $99
  • Meals for Acthar · 2020-01-08 · $22
Kala PharmaceuticalsEysuvis$12,750
3 payments
  • Consulting for Eysuvis · 2020-12-18 · $850
  • Consulting for Eysuvis · 2020-12-18 · $3,825
  • Consulting for Eysuvis · 2020-12-04 · $8,075
F. Hoffmann-La Roche AGNone$10,740
2 payments
  • Consulting · 2020-04-01 · $5,370
  • Consulting · 2020-04-01 · $5,370
Sanofi US ServicesNone$10,335
1 payment
  • Consulting · 2020-08-03 · $10,335
AmgenNone$6,972
5 payments
  • Consulting · 2020-12-09 · $850
  • Meals · 2020-01-10 · $64
  • Travel · 2020-01-10 · $107
  • Consulting · 2020-01-10 · $2,550
  • Consulting · 2020-01-10 · $3,400
Boehringer Ingelheim PharmaceuticalsNone$6,218
9 payments
  • Travel · 2020-09-22 · $140
  • Consulting · 2020-09-22 · $5,450
  • Meals · 2020-09-22 · $35
  • Meals · 2020-02-22 · $16
  • Meals · 2020-02-22 · $53
  • Meals · 2020-02-22 · $121
  • Meals · 2020-02-22 · $92
  • Meals · 2020-02-22 · $16
  • Travel · 2020-02-22 · $296
GenentechNone$2,530
1 payment
  • Consulting · 2020-06-27 · $2,530
AllerganOzurdex$1,184
3 payments
  • Meals for Ozurdex · 2020-02-21 · $33
  • Meals · 2020-02-21 · $88
  • Consulting · 2020-01-01 · $1,063
Regeneron PharmaceuticalsEylea$1,060
1 payment
  • Consulting for Eylea · 2020-01-30 · $1,060
Novartis PharmaceuticalsNone$49
1 payment
  • Meals · 2020-01-21 · $49

2019: $70,572

Payments by company in 2019
Bausch & Lomb a division of Bausch Health USRetisert$24,140
6 payments
  • Meals for Visudyne · 2019-08-29 · $76
  • Meals for Stellaris PC · 2019-08-28 · $43
  • Meals for Stellaris PC · 2019-08-21 · $14
  • Consulting for Retisert · 2019-08-20 · $1,500
  • Meals for Doctors Allergy Formula · 2019-05-29 · $7
  • Grant · 2019-01-23 · $22,500
Mallinckrodt EnterprisesActhar$22,307
15 payments
  • Consulting for Acthar · 2019-11-08 · $3,000
  • Travel for Acthar · 2019-11-08 · $467
  • Travel for Acthar · 2019-11-08 · $81
  • Travel for Acthar · 2019-11-08 · $87
  • Meals for Acthar · 2019-10-13 · $125
  • Paid to speak or teach for Acthar · 2019-09-16 · $3,100
  • Paid to speak or teach for Acthar · 2019-09-09 · $9,000
  • Paid to speak or teach for Acthar · 2019-08-26 · $3,100
  • Meals for Acthar · 2019-08-13 · $125
  • Paid to speak or teach for Acthar · 2019-07-31 · $3,100
  • Meals for Acthar · 2019-07-28 · $41
  • Meals for Acthar · 2019-07-18 · $7
  • Meals for Acthar · 2019-07-18 · $10
  • Meals for Acthar · 2019-05-24 · $35
  • Meals for Acthar · 2019-04-20 · $29
F. Hoffmann-La Roche AGLucentis$17,743
13 payments
  • Paid to speak or teach for Non-Covered Product · 2019-12-31 · $1,198
  • Paid to speak or teach for Lucentis · 2019-12-31 · $3,501
  • Paid to speak or teach for Lucentis · 2019-12-31 · $952
  • Paid to speak or teach for Non-Covered Product · 2019-09-30 · $1,787
  • Paid to speak or teach for Non-Covered Product · 2019-09-30 · $567
  • Paid to speak or teach for Lucentis · 2019-09-30 · $1,445
  • Paid to speak or teach for Lucentis · 2019-06-30 · $1,702
  • Paid to speak or teach for Lucentis · 2019-06-30 · $1,350
  • Paid to speak or teach for Lucentis · 2019-06-30 · $2,286
  • Paid to speak or teach for Lucentis · 2019-03-31 · $378
  • Paid to speak or teach for Lucentis · 2019-03-31 · $1,142
  • Paid to speak or teach for Lucentis · 2019-03-31 · $952
  • Paid to speak or teach for Non-Covered Product · 2019-03-31 · $486
EyePoint Pharmaceuticals USYutiq$2,315
2 payments
  • Consulting for Yutiq · 2019-08-30 · $2,250
  • Meals for Yutiq · 2019-07-29 · $65
Kala PharmaceuticalsNone$1,700
1 payment
  • Consulting · 2019-08-16 · $1,700
AmgenNone$1,455
5 payments
  • Consulting · 2019-10-09 · $850
  • Travel · 2019-05-06 · $147
  • Travel · 2019-05-06 · $130
  • Travel · 2019-04-30 · $150
  • Travel · 2019-04-30 · $178
Aerie PharmaceuticalsRocklatan$301
5 payments
  • Meals · 2019-10-12 · $42
  • Meals · 2019-07-23 · $94
  • Meals · 2019-07-23 · $127
  • Meals for Rocklatan · 2019-04-29 · $4
  • Meals · 2019-02-09 · $34
GenentechLucentis$269
3 payments
  • Meals for Lucentis · 2019-10-15 · $45
  • Meals for Lucentis · 2019-06-10 · $102
  • Meals for Lucentis · 2019-01-10 · $123
Alimera SciencesIluvien$147
2 payments
  • Meals for Iluvien · 2019-09-23 · $125
  • Meals for Iluvien · 2019-07-24 · $22
Boehringer Ingelheim PharmaceuticalsNone$113
1 payment
  • Meals · 2019-07-28 · $113
Regeneron Healthcare SolutionsEylea$67
1 payment
  • Meals for Eylea · 2019-07-28 · $67
AbbVieHumira$15
1 payment
  • Meals for Humira · 2019-03-07 · $15

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Mallinckrodt Hospital Products Inc. · Acth As A Re-Emerging Therapy for Uveitis (the Acthar Study) · 2020Their institution$294,576
Mallinckrodt Hospital Products Inc. · Acth As A Re-Emerging Therapy for Uveitis (the Acthar Study) · 2024Their institution$276,157
Mallinckrodt Enterprises LLC · Acth As A Re-Emerging Therapy for Uveitis the Acthar Study · 2019Their institution$267,802
Mallinckrodt Hospital Products Inc. · Acth As A Re-Emerging Therapy for Uveitis (the Acthar Study) · 2022Their institution$267,480
Gilead Sciences, Inc. · A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects With Active Non Infectious Uveitis · 2020Their institution$180,822
Gilead Sciences, Inc. · A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects With Active Non Infectious Uveitis · 2019Their institution$143,925
Novartis Pharmaceuticals Corporation · A Multicenter Randomized Double Masked Phase 3a Study To Assess Safety and Efficacy of Brolucizumab 6 Mg Q4 Weeks Compared To Aflibercept 2 Mg Q4 Weeks in Patients With Neovascular Age Related Macular Degeneration Namd With Persistent Retinal Fluid · 2020Their institution$134,222
Boehringer Ingelheim Pharmaceuticals, Inc. · Anti Sema3a for Dmi in Treated Pdr Patients · 2021Their institution$35,857
Novartis Pharmaceuticals Corporation · A Multicenter Randomized Double Masked Phase 3a Study To Assess Safety and Efficacy of Brolucizumab 6 Mg Q4 Weeks Compared To Aflibercept 2 Mg Q4 Weeks in Patients With Neovascular Age Related Macular Degeneration Namd With Persistent Retinal Fluid · 2021Their institution$34,215
Roche TCRC, Inc. · Ro7200220 for Diabetic Macular Edema · 2020Their institution$33,046
Boehringer Ingelheim Pharmaceuticals, Inc. · Ph2a Pom in Npdr Bi 1467335 Vs Plc 12 Wk · 2019Their institution$31,846
Biogen, Inc. · An Open-Label Safety Study of Retinal Gene Therapy for Choroideremia With Bilateral, Sequential Administration of Adeno-Associated Viral Vector (Aav2) Encoding Rab Escort Protein 1 (Rep1) · 2022This clinician$31,200
Aerie Pharmaceuticals, Inc. · A Multicenter, Open-Label, Safety and Proof-of-Concept Study To Assess Safety, Tolerability and Efficacy of Ar-1105 in Subjects With Macular Edema Due To Retinal Vein Occlusion (Rvo) · 2020Their institution$30,238
Novartis Pharmaceuticals Corporation · A Multicenter Randomized Double Masked Phase 3a Study To Assess Safety and Efficacy of Brolucizumab 6 Mg Q4 Weeks Compared To Aflibercept 2 Mg Q4 Weeks in Patients With Neovascular Age Related Macular Degeneration Namd With Persistent Retinal Fluid · 2019Their institution$28,735
Gilead Sciences, Inc. · A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects With Active Non Infectious Uveitis · 2021Their institution$28,256
Boehringer Ingelheim Pharmaceuticals, Inc. · Srd Mrd Iia · 2022Their institution$25,687
Boehringer Ingelheim International GmbH · Crimson: A Multicentre, Randomised, Sham-Controlled (and Active Controlled in the USA), Double-Masked, 72-Week Trial To Study the Safety, Tolerability, Pharmacokinetics, and Efficacy of 3 Dosing Regimens of Intravitreal Bi 764524 in Patients With Moderately Severe To Severe Non-Proliferative Diabetic Retinopathy · 2025Their institution$25,443
Boehringer Ingelheim Pharmaceuticals, Inc. · Anti Sema3a for Dmi in Treated Pdr Patients · 2023Their institution$22,213
Aerie Pharmaceuticals, Inc. · A Multicenter, Open-Label, Safety and Proof-of-Concept Study To Assess Safety, Tolerability and Efficacy of Ar-1105 in Subjects With Macular Edema Due To Retinal Vein Occlusion (Rvo) · 2019Their institution$21,429
Biogen, Inc. · An Open-Label Safety Study of Retinal Gene Therapy for Choroideremia With Bilateral, Sequential Administration of Adeno-Associated Viral Vector (Aav2) Encoding Rab Escort Protein 1 (Rep1) · 2020This clinician$21,400
Novartis Pharmaceuticals Corporation · A Multicenter Randomized Double Masked Phase 3a Study To Assess Safety and Efficacy of Brolucizumab 6 Mg Q4 Weeks Compared To Aflibercept 2 Mg Q4 Weeks in Patients With Neovascular Age Related Macular Degeneration Namd With Persistent Retinal Fluid · 2022Their institution$20,641
Boehringer Ingelheim Pharmaceuticals, Inc. · Pocp Npdr Study, 1 Dose Vs Placebo, 12 Wk · 2022Their institution$17,815
Boehringer Ingelheim International GmbH · Bi 764524 Phase 2b · 2024Their institution$17,621
Boehringer Ingelheim Pharmaceuticals, Inc. · Srd Mrd Pocm in Wamd · 2021Their institution$16,471
Boehringer Ingelheim Pharmaceuticals, Inc. · Srd Mrd Pocm in Wamd · 2023Their institution$15,387
Aerie Pharmaceuticals, Inc. · A Study Assessing Ar-13503 Implant Alone and in Combination With Aflibercept in Subjects With Namd Or Dme · 2019Their institution$14,727
Biogen, Inc. · A Randomised, Open Label, Outcomes-Assessor Masked, Prospective, Parallel Controlled Group, Phase 3 Clinical Trial of Retinal Gene Therapy for Choroideremia Using An Adeno-Associated Viral Vector (Aav2) Encoding Rab Escort Protein 1 (Rep1) · 2020This clinician$13,800
EyePoint Pharmaceuticals US, Inc. · A Phase 3, Multicenter, Prospective, Randomized, Masked, Controlled, Safety and Efficacy Study of A Fluocinolone Acetonide (Fa) Intravitreal 0.05 Mg Insert (Yutiq 0.05 Mg) in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye · 2023Their institution$11,297
Boehringer Ingelheim International GmbH · Eye Dmi Epidemiology Study · 2023Their institution$5,748
Boehringer Ingelheim Pharmaceuticals, Inc. · Srd/Mrd/Iia · 2024Their institution$5,549
Boehringer Ingelheim Pharmaceuticals, Inc. · Ph2a Pom in Npdr Bi 1467335 Vs Plc 12 Wk · 2020Their institution$5,283
F. Hoffmann-La Roche AG · Has the Time Come To Re-Evaluate the Treatment Paradigm for Diabetic Retinopathy · 2020This clinician$5,114
F. Hoffmann-La Roche AG · A Phase III, Double-Masked, Multicenter, Randomized, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus, A Phase III, Double-Masked, Multicenter, Randomized, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus · 2020This clinician$4,225
Boehringer Ingelheim International GmbH · Eye-Dmi Epidemiology Study · 2021Their institution$3,928
Boehringer Ingelheim Pharma GmbH & Co.KG · Srd/Mrd/Pocm in Wamd · 2021Their institution$3,904
Boehringer Ingelheim International GmbH · Eye-Dmi Epidemiology Study · 2024Their institution$3,846
Boehringer Ingelheim Pharmaceuticals, Inc. · Anti Sema3a for Dmi in Treated Pdr Patients · 2022Their institution$3,833
Roche TCRC, Inc. · O7200220 for Diabetica and Uveitica Macular Edema · 2021Their institution$3,670
Regeneron Pharmaceuticals, Inc. · Health Economics Outcome Research Related To Opthalmology · 2023This clinician$3,380
Boehringer Ingelheim Finland Ky · Anti-Sema3a for Dmi in Treated Pdr Patients · 2021Their institution$3,304
Boehringer Ingelheim International GmbH · Eye Dmi Epidemiology Study · 2022Their institution$2,805
Boehringer Ingelheim Pharma GmbH & Co.KG · Srd Mrd Pocm in Wamd · 2023Their institution$2,746
EyePoint Pharmaceuticals US, Inc. · Safety and Efficacy of An Injectable Fluocinolone Acetonide Intravitreal Insert · 2019Their institution$2,108
F. Hoffmann-La Roche AG · Harbor 1 · 2023This clinician$1,961
Boehringer Ingelheim Pharma GmbH & Co.KG · Srd Mrd Pocm in Wamd · 2022Their institution$1,784
Regeneron Pharmaceuticals, Inc. · Eylea Clinical Development Program · 2024This clinician$1,665
Regeneron Pharmaceuticals, Inc. · Eylea Clinical Development Program · 2025This clinician$1,500
Regeneron Pharmaceuticals, Inc. · Eylea Clinical Development Program · 2021This clinician$905
Boehringer Ingelheim Finland Ky · Srd/Mrd/Iia · 2021Their institution$860
Boehringer Ingelheim Pharma GmbH & Co.KG · Srd/Mrd/Pocm in Wamd · 2020Their institution$839
Regeneron Pharmaceuticals, Inc. · Health Economics Outcome Research Related To Opthalmology · 2021This clinician$812
Regeneron Pharmaceuticals, Inc. · Eylea Clinical Development Program · 2023This clinician$411
Boehringer Ingelheim Pharmaceuticals, Inc. · Anti-Sema3a for Dmi in Treated Pdr Patients · 2024Their institution$67
Gilead Sciences, Inc. · A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects With Active Non Infectious Uveitis · 2019This clinician$61

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
80.6 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1487608766
Licence
CA G144498, MD D53275California G144498: Current · expires 2028-07-31
Trained
Perelman School of Med at the University of Pennsylvania, 1994
Group
Stanford Health Care · County of Santa Clara
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
MD 155300300
Taxonomy
Federal specialty code 207WX0108X (207WX0108X); Federal specialty code 207W00000X (207W00000X); Federal specialty code 207WX0107X (207WX0107X)
Mailing address
1804 Embarcadero Rd, Ste 100, Palo Alto, CA, 94303
NPI first listed
2006-05-20
NPI last updated
2024-04-04
NPI record certified
2024-04-04

This is when the NPI record was last certified, not a medical board exam.